Instalab
logoInstalab

BMD Z-Score (Left Total Hip)

See how your hip bone stacks up against your peers, and catch bone loss before it becomes a fracture.

Should you take a BMD Z-Score (Left Total Hip) test?

This test is most useful if any of these apply to you.

Healthy but Want to Stay Ahead
Get a baseline now so you can see the trend, not just a single number, decades before fracture risk becomes a problem.
Going Through or Past Menopause
Estrogen drops accelerate bone loss; this scan shows whether your hip is keeping up or quietly slipping behind your peers.
Taking Long-Term Steroids
Oral glucocorticoids are one of the most consistent causes of hip bone loss, and you should know your number before damage compounds.
Pushing Your Fitness Further
Endurance athletes, especially cyclists and runners with low body weight, often have surprisingly low hip density despite peak fitness.

About BMD Z-Score (Left Total Hip)

Your hip is the single most consequential bone in your body. A hip fracture in later life can end independence, mobility, and for many people, life itself. The good news is that you can see trouble coming decades before it arrives, and this measurement is one of the clearest early signals.

The BMD Z-score (bone mineral density Z-score) at the left hip tells you how your hip bone density compares to other healthy people who share your age and sex. It answers a question a basic physical cannot: is your skeleton aging on track, ahead of schedule, or falling behind your peers?

What This Measurement Actually Captures

A bone density scan, called DXA (dual-energy X-ray absorptiometry), measures the mineral content of your hip bone in grams per square centimeter. That raw number is then compared to a reference database of healthy people your age and sex. The result is reported as a Z-score, which represents the number of standard deviations your value sits above or below the average for your peer group.

This is different from a T-score, which compares your bones to a healthy young adult at peak bone mass. T-scores define osteoporosis and osteopenia. Z-scores answer a different question: are you keeping up with your own age group? In premenopausal women and men under 50, Z-scores are the preferred way to interpret the scan. In older adults, both numbers matter, but Z-scores reveal whether something unusual is driving bone loss beyond what aging alone would explain.

The hip is built and remodeled constantly by two types of cells: bone-building cells (osteoblasts) and bone-removing cells (osteoclasts). Your Z-score reflects the long-term balance between these two processes at the proximal femur. When formation keeps pace with breakdown, density stays stable. When breakdown wins, the number drops.

Why The Hip Matters More Than Other Sites

You can measure bone density at the spine, wrist, or hip, and the numbers do not always agree. Spine and hip readings can diverge in the same person, and even the left and right hip can give different results. Relying on a single site or a single hip can miss low bone density elsewhere.

The hip carries unique weight in fracture prediction. In a meta-analysis pooling roughly 39,000 adults, each one standard deviation drop in femoral neck density was associated with about three times the risk of hip fracture at age 65. After a hip fracture, lower hip density also predicts higher mortality, making this site one of the most actionable bone measurements you can track.

Fracture Risk

Lower hip density translates directly into broken bones. In a study of about 273,000 Asian women, each one-unit decline in hip density score was associated with roughly two times higher risk of hip fracture. In type 2 diabetes, where bones can look stronger on a scan than they truly are, femoral neck density still predicted hip, non-spine, and major osteoporotic fractures across more than 42,000 people, with the same gradient as people without diabetes.

What this means for you: even modest reductions, in the range of one standard deviation below your peers, are not background noise. They are early warnings that the cumulative balance of bone formation and breakdown has tipped against you.

Mortality After Hip Fracture

In a prospective cohort of 411 adults who had already broken a hip, lower hip density independently predicted death after surgery. Separately, in elderly men, low hip density was a strong and independent predictor of both all-cause and cardiovascular mortality. The bone is not the only thing dying when density drops; it tracks something deeper about overall resilience.

Cardiovascular Disease

In a study of 12,681 Asian women, lower hip density independently predicted future heart attacks, strokes, and cardiovascular death, even after accounting for standard risk factors. A meta-analysis of prospective cohort studies found that lower bone density was associated with increased all-cause and cardiovascular mortality, though not stroke mortality specifically. The reasons are not fully understood, but bone and artery health appear to share metabolic pathways.

Chronic Kidney Disease

In people on dialysis or with advanced kidney disease, lower hip density predicts both fracture and earlier death. A meta-analysis confirmed that lower density at the hip, arm, spine, and whole body was associated with higher all-cause mortality across kidney disease populations. If your kidneys are compromised, your bones almost certainly are too.

Secondary Causes of Low Hip Density

Several systemic conditions show up at the hip as a Z-score that drifts below the expected range. Each has its own pattern worth knowing about.

  • Sickle cell disease: roughly 43% of adults studied had a hip Z-score at or below -2, and lower density was tied to worse pain.
  • Early rheumatoid arthritis: people with high levels of certain autoantibodies (ACPA, a marker that targets the body's own proteins, and rheumatoid factor) showed reduced spine and hip Z-scores even before treatment.
  • Elite cycling: despite being world-class athletes, many elite cyclists had hip and femoral neck Z-scores below -1, linked to low body mass, limited bone-loading activity, and low energy availability.
  • Arthrogryposis multiplex congenita: adults with this neuromuscular condition showed mean femoral neck Z-scores around -1.1 and total hip around -1.2, with 22 to 25% below -2.

Research-Based Reference Ranges

These ranges are drawn from clinical guidance and published research, primarily through DXA measurement in grams per square centimeter converted to standard deviations. Hip Z-score interpretation differs by age group: in premenopausal women and men under 50, Z-scores are the primary tool. In older adults, T-scores carry diagnostic weight, but Z-scores still tell you whether something beyond normal aging is at work. Reference databases vary by manufacturer, and within one manufacturer, different databases can shift a Z-score by up to one full standard deviation.

Z-Score RangeInterpretationWhat It Suggests
Above 0Above average for ageHip density is stronger than typical peers
0 to -1.0Within expected rangeBone density tracking normally for your age and sex
-1.0 to -2.0Lower end of expected rangeWorth investigating contributors, especially if other risk factors exist
At or below -2.0Below expected range for ageWarrants workup for secondary causes and fracture risk assessment

Compare your results within the same lab and ideally the same DXA machine over time for the most meaningful trend. Machine-to-machine differences and reference database variability mean a single number from one scanner is less informative than the trajectory across repeat scans at the same facility.

Tracking Your Trend

A single hip Z-score is a snapshot. The real signal is in the slope. Bone density changes slowly, on a timescale of months to years rather than days, so chasing the number too often is wasteful, but ignoring it is worse. Reproducibility studies show that a change exceeding the least significant change threshold, typically a few percent, is needed before you can say a real shift has occurred rather than measurement noise.

To stay ahead of bone loss: get a baseline scan now if you are over 40, or earlier if you have risk factors like family history of osteoporosis, prior fracture, low body weight, chronic steroid use, or a condition that affects bone. Repeat in one to two years if you are making changes, and at least every two years if you are stable. If you are starting treatment for low bone density, retest at one year to confirm response.

What an Abnormal Result Should Make You Do

If your hip Z-score comes back at or below -2.0, the next step is not to wait. The first move is to look for a secondary cause. Order a workup that includes vitamin D, calcium, parathyroid hormone (a regulator of calcium balance), thyroid function, kidney function, and in some cases testosterone or estradiol depending on age and sex. Celiac antibodies and a 24-hour urine calcium can catch hidden malabsorption or excess loss.

If a single Z-score is borderline or you have other fracture risk factors, an endocrinologist or a doctor who focuses on bone metabolism can help interpret the full picture. Adding a trabecular bone score (a refinement that estimates internal bone structure from the same DXA scan) or imaging like high-resolution peripheral CT can sharpen the assessment. Treatment decisions hinge on both the Z-score and the broader fracture risk profile, not the density number alone.

When Results Can Be Misleading

Hip density scans have known pitfalls. Knowing them keeps you from chasing false alarms or being falsely reassured.

  • Positioning and machine differences: rotation of the hip during scanning, region-of-interest definition, and cross-calibration differences between DXA machines can shift the number enough to change diagnostic categories. This is why same-lab, same-machine retesting matters.
  • Reference database choice: even within one manufacturer, different reference databases can shift Z-scores by close to one standard deviation. Ethnicity-specific references (e.g., Chinese versus Caucasian) can reclassify a substantial portion of results.
  • Hip-to-hip and spine-to-hip discordance: the left and right hip can disagree, as can hip and spine. A normal reading at one site does not rule out low density elsewhere.
  • Degenerative changes: arthritis, calcified blood vessels, or fractures in the area being scanned can falsely raise the apparent density and mask true bone loss.

What Moves This Biomarker

Evidence-backed interventions that affect your BMD Z-Score (Left Total Hip) level

Increase
Denosumab (a twice-yearly injection that blocks bone breakdown)
In a meta-analysis comparing denosumab to bisphosphonates in osteoporosis patients, denosumab produced larger gains in bone density and greater reductions in fracture risk. Hip density increased significantly more than with bisphosphonates over the same period. Worth considering when bisphosphonates fail or are not tolerated.
MedicationStrong Evidence
Increase
Romosozumab (a monthly injection that both builds bone and slows breakdown)
In a phase 3 trial of 436 postmenopausal women transitioning from oral bisphosphonates, romosozumab produced significantly larger gains in hip bone mineral density than teriparatide over 12 months. The hip benefit is what sets it apart, since teriparatide builds spine bone more reliably than hip bone.
MedicationStrong Evidence
Increase
Teriparatide (a daily injection of a parathyroid hormone fragment that stimulates new bone formation)
In a meta-analysis of osteoporosis patients not previously on bisphosphonates, teriparatide was superior to bisphosphonates in reducing fracture risk. Hip density gains are smaller than spine gains, but the bone formation effect is real and especially useful when the priority is rebuilding bone, not just stopping loss.
MedicationStrong Evidence
Decrease
Long-term systemic glucocorticoid use (oral steroids like prednisone)
Glucocorticoids directly suppress bone-building cells and accelerate bone-removing cells. In a study of 1,155 older inpatients, systemic glucocorticoid use was associated with significantly lower hip bone density after adjusting for other factors. This is one of the most consistent drug-induced causes of hip bone loss and should trigger preventive treatment when steroids are used long-term.
MedicationStrong Evidence
Increase
Bisphosphonates (alendronate, zoledronate, and similar drugs)
These are the first-line drugs for low hip bone density. In a real-world analysis of 15,395 patients, total hip density rose progressively in people taking bisphosphonates, and that gain translated into lower fracture risk. They work by slowing the cells that break down bone, letting formation catch up. Expect measurable density gains over one to three years.
MedicationModerate Evidence
Increase
Progressive resistance training (weightlifting that gets harder over time)
In a meta-analysis of older adults, progressive resistance training increased both muscle strength and bone mineral density. A separate meta-analysis in postmenopausal women found that high-intensity resistance training over longer durations produced the largest hip density gains. Loading bone directly tells it to stay dense.
ExerciseModerate Evidence
Increase
Combined aerobic and resistance training during weight loss
In a randomized trial of 160 older adults with obesity who were dieting, resistance training alone or combined with aerobic exercise protected against the bone loss that typically accompanies weight loss. Without exercise, dieting alone can lower hip density. This matters if you are losing weight on purpose, including with GLP-1 medications.
ExerciseModerate Evidence
Increase
Estrogen replacement (transdermal estradiol or oral hormone therapy)
In a 12-month randomized trial of 121 oligo-amenorrhoeic athletes (women whose periods had stopped due to low energy availability), transdermal estradiol improved hip bone density compared to oral contraceptives containing ethinyl estradiol. Low-dose hormone therapy in postmenopausal women also improved density and reduced bone turnover compared to raloxifene.
MedicationModerate Evidence
Decrease
Aromatase inhibitors (drugs that block estrogen production, used in breast cancer)
In registry data, aromatase inhibitor use was associated with higher odds of significant hip and spine density loss over time. The mechanism is reduced estrogen, which is essential for maintaining bone density in women. Cytotoxic chemotherapy in postmenopausal breast cancer also drops femoral neck and total hip density by roughly 2 to 3% over six months.
MedicationModerate Evidence
Decrease
Smoking cigarettes
Smoking is one of the clinical risk factors used in fracture prediction tools like FRAX (a calculator that estimates 10-year fracture risk). It contributes to lower hip bone density independent of other risk factors and increases hip fracture risk meaningfully. Quitting allows partial recovery over years.
LifestyleModerate Evidence
Increase
Combined calcium and vitamin D supplementation
In a meta-analysis of randomized trials in postmenopausal women with osteoporosis, combined calcium and vitamin D supplementation improved pelvic bone density and corrected vitamin D deficiency. Hip fracture risk was reduced in a separate meta-analysis. Vitamin D alone, without calcium, shows little benefit at the hip in most trials.
SupplementModest Evidence

Frequently Asked Questions

References

36 studies
  1. Johnell O, Kanis J, Odén a, Johansson H, De Laet C, Delmas P, Eisman J, Fujiwara S, Kroger H, Mellstrom D, Meunier P, Melton L, O'neill T, Pols H, Reeve J, Silman a, Tenenhouse aJournal of Bone and Mineral Research2005
  2. Lo JC, Chandra M, Yang W, Darbinian J, Wheeler AL, Gordon NP, Lee COsteoporosis International2025
  3. Ge Y, Chen Y, Liu G, Zhu S, Li B, Tian M, Zhang J, Wu X, Yang MCalcified Tissue International2023
  4. Van Hulten V, Driessen JHM, Andersen S, Kvist a, Viggers R, Bliuc D, Center JR, Brouwers MCJG, Vestergaard P, Bergh JPDiabetes, Obesity and Metabolism2024
  5. Qu X, Huang X, Jin F, Wang H, Hao Y, Tang T, Dai KInternational Journal of Cardiology2013